Influenza A virus H3N2 (Brisbane) Antigen

Specification

• Cat#: VAC-0271
• Product Name: Influenza A virus H3N2 (Brisbane) Antigen
• Description: Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Brisbane/10/07. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
• Species: Influenza A virus
• Introduction: H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses.
• Purity: Greater than 90.0% as determined byAnalysis by SDS-PAGE.
• Formulation: The H3N2 A/Brisbane/10/07 solution contains STE, 0.1% sodium azide (NaN3) and 0.005% thimerosal.
• Stability: A/Brisbane/10/07although stable 4°C for 4 weeks, should be stored below -18°C.Please prevent freeze-thaw cycles.
• Physical Appearance: Sterile Filtered whitish (milky) solution.
• Usage: All the products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.